Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Sharkey

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994
Immunoscintigraphy of Pneumocystis carinii pneumonia in AIDS patientsD M Goldenberg, R M Sharkey, S Udem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCRM E Juweid, G Hajjar, R Stein, et al.
Seminars in Nuclear Medicine|October 1, 1989
Imaging of colorectal carcinoma with radiolabeled antibodiesD M Goldenberg, H Goldenberg, R M Sharkey, et al.
Bioconjugate Chemistry|November 17, 1998
90Yttrium-labeled complementarity-determining-region-grafted monoclonal antibodies for radioimmunotherapy: radiolabeling and animal biodistribution studiesS V Govindan, L B Shih, D M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodiesM Juweid, R M Sharkey, T Behr, et al.
Bioconjugate Chemistry|January 3, 2014
Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumorsS Lütje, G M Franssen, R M Sharkey, et al.
Cancer Research|February 1, 1990
Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imagingH J Hansen, A L Jones, R M Sharkey, et al.
Cancer Research|December 1, 1995
Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studiesR M Sharkey, M Juweid, J Shevitz, et al.
Cancer Research|April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumorsT M Behr, R M Sharkey, M I Juweid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibodyD M Goldenberg, J A Horowitz, R M Sharkey, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994
Immunoscintigraphy of Pneumocystis carinii pneumonia in AIDS patientsD M Goldenberg, R M Sharkey, S Udem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCRM E Juweid, G Hajjar, R Stein, et al.
Seminars in Nuclear Medicine|October 1, 1989
Imaging of colorectal carcinoma with radiolabeled antibodiesD M Goldenberg, H Goldenberg, R M Sharkey, et al.
Bioconjugate Chemistry|November 17, 1998
90Yttrium-labeled complementarity-determining-region-grafted monoclonal antibodies for radioimmunotherapy: radiolabeling and animal biodistribution studiesS V Govindan, L B Shih, D M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodiesM Juweid, R M Sharkey, T Behr, et al.
Bioconjugate Chemistry|January 3, 2014
Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumorsS Lütje, G M Franssen, R M Sharkey, et al.
Cancer Research|February 1, 1990
Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imagingH J Hansen, A L Jones, R M Sharkey, et al.
Cancer Research|December 1, 1995
Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studiesR M Sharkey, M Juweid, J Shevitz, et al.
Cancer Research|April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumorsT M Behr, R M Sharkey, M I Juweid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibodyD M Goldenberg, J A Horowitz, R M Sharkey, et al.
Pageof 15